D-Heart is a health tech startup with a mission to revolutionize heart health management. Founded in 2015, the company has developed the first smartphone ECG device that is not only simple to use but also clinically reliable, portable, and affordable. This innovation enables individuals to perform hospital-level ECG tests autonomously and transmit the results to a 24/7 telecardiology service or their trusted doctor. The device, which has received the CE mark and recognized as IIa for home care use, can record 8 and 12 leads without the need for hospital visits. Leveraging image processing and artificial intelligence, D-Heart empowers users to actively engage in their health management within seconds. The startup recently secured a Seed Round investment from iStarter in October 2018. With this support, D-Heart is expanding its reach internationally, particularly in Asia, Africa, Australia, New Zealand, the Middle East, and various European countries. The expansion is driven by the company's commitment to quality standards, cutting-edge technology, exemplary design, and the value of being "Made in Italy." The company's slogan, "Check your Heart anywhere, anytime," encapsulates its vision to make heart health monitoring convenient and accessible for individuals. To learn more about D-Heart and its groundbreaking ECG technology, visit their website at www.d-heartcare.com.
No recent news or press coverage available for D-Heart.